Avanos Medical Inc. Stock News

Avanos Medical Inc:

Avanos Medical, Inc. (NYSE: AVNS) today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its new, 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion pro

Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two investor conferences in March:

Avanos Medical (NYSE:AVNS) is scheduled to be releasing its earnings data before the market opens on Tuesday, February 25th. Analysts expect Avanos Medical to post earnings of $0.32 per share for the

Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M

Analysts predict that Avanos Medical Inc (NYSE:AVNS) will report $177.83 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Avanos Medical’

Brokerages expect Avanos Medical Inc (NYSE:AVNS) to post earnings per share of $0.32 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for

North Star Asset Management Inc. reduced its position in Avanos Medical Inc (NYSE:AVNS) by 2.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 27,131 shares of the comp

ALPHARETTA, Ga., Feb. 11, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full-y

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN ) Aptose Bioscie

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Avanos Medical (NYSE:AVNS) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of thei

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics